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Condylar hyperplasia: An updated review of the 
literature
Condylar hyperplasia (CH) is a rare disorder characterized by excessive bone 
growth that almost always presents unilaterally, resulting in facial asymmetry. 
Classification of the different types of CH can differ depending on the authors. 
Correct diagnosis is critical in determining the proper treatments and timing. 
This paper is a review of the recent literature on the epidemiology, etiology, 
diagnosis, classification, and surgical treatments of CH.
[Korean J Orthod 2015;45(6):333-340]
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INTRODUCTION
  Condylar hyperplasia (CH) is a rare disorder charac-
terized by excessive bone growth that usually presents 
unilaterally, resulting in facial asymmetry.1 Its etiology 
and pathogenesis are poorly understood. Facial asym-
metry is often the reason that patients present for 
treatment of the disorder. In many cases, occlusal dis-
crepancies and temporomandibular joint disorder are 
concurrent symptoms with facial asymmetry. An attempt 
has been made to separate and classify different types 
of CH based on clinical characteristics and etiology.2 In 
1986, Obwegeser and Makek3 specifically detailed two 
hemimandibular anomalies, hemimandibular hyperplasia 
and hemimandibular elongation. These anomalies can 
be clinically present in a pure form or in combination. 
Many diagnostic tools and criteria have been used to aid 
in the correct diagnosis of CH, which in turn is critical 
to determining the appropriate treatments and timing. 
With proper diagnosis, timing, and treatment, CH can be 
effectively treated with a high success rates. 
MAIN SUBJECTS
Epidemiology and etiology
  CH can occur at any age and can continue past the 
growth period.4 Previous literature has suggested that 
CH may predominantly affect women.4 A meta-analysis 
was conducted by Raijmakers et al.5 in 2012 to assess 
this hypothesis, which revealed that women develop 
CH significantly more frequently, with 64% (95% CI, 
58−70%; n = 275 patients) of CH patients being 
women. CH was also proposed to demonstrate sex-based 
laterality, with women and men affected more frequently 
on the right and left side, respectively.4 However, the 
meta-analysis by Raijmakers et al.5 did not find any 
evidence that the side affected by CH was linked to sex. 
Current research has yet to define an exact etiology for 
CH. Possible etiologies include endocrine distortions 
(e.g., insulin-like growth factors [IGFs]), metabolic 
hyperactivity, trauma, arthrosis, and genetics. Typical 
man dibular condyle soft tissue histology includes four 
layers: fibrous articular layer, undifferentiated mesen-
chymal layer, transitional layer, and hypertrophic car-
tilage layer.6 Active CH has been found to display a 
broa der mesenchymal layer than that in the normal con-
dyle.7
  IGF-1 and IGF-1 receptor (IGF-1R) expression was 
found to significantly increase in chondrocytes affected 
by CH.7 IGF-1 is an essential growth modulator that has 
been described as a pathological factor when produced 
in excess8 and ‘has been shown to reach higher-than-
normal levels in CH’.7,9 In an in vitro model, Chen et 
al.7 demonstrated that IGF-1 was able to significantly 
increase the proliferation of chondrocytes from the 
cartilage of normal condyles and, conversely, that NVP-
AEW541 (an inhibitor of IGF-1R kinase) was able to 
significantly decrease the proliferation capacity of 
chondrocytes cultured from CH. Gene expression of 
collagen type II A1 (COL2A1) was found to significantly 
increase in CH compared to that in normal condylar 
cartilage, and when chondrocytes from normal condylar 
cartilage were treated with IGF-1, gene expression of 
COL2A1 also significantly increased. However, when 
CH chondrocytes were treated with NVP-AEW541, no 
significant reduction in COL2A1 expression occurred.7 
These results indicate that IGF-1 has an impact on chon-
drogenesis of the mandibular condyle; however, the ex-
tent and full underlying mechanism of this effect is not 
known.
  A study by Saridin et al.10 analyzed metabolism 
and blood flow in seven patients (mean age 25.5 
years) with unilateral CH using 18F and H2
15O positron 
emission tomography (PET) imaging. Four patients had 
hemimandibular elongation, one had hemimandibular 
hyperplasia, and two had a combination of these ano-
malies. Their results highlighted the possibility that 
CH can also be caused by a decrease in growth activity 
of the contralateral condyle with normal growth 
in the affected condyle. In patients with condylar 
hyperactivity, 18F uptake, used to assess bone formation, 
was significantly higher in the affected condyle than in 
the contralateral condyle.10 However, the 18F uptake of 
the hyperactive condyles was similar to that of con trol 
condyles, while the contralateral condyles had signi-
ficantly less 18F uptake than control condyles.10 These 
results suggest that in this patient sample, the affected 
condyle grows at a normal rate, while a cessation of 
growth occurs in the contralateral condyle. In contrast 
to previous literature,11 the study by Saridin et al.10 did 
not find any relationship between bone formation and 
blood flow.
Diagnosis
  Various methods are available for the diagnosis of 
CH. Correct diagnosis of CH is essential when deciding 
how to treat the condition. To prevent post-surgical 
reversion, accurate diagnosis of CH activity is also of 
upmost importance.12 Diagnostic methods such as cli-
nical examination, radiographs, and nuclear imaging 
(Figure 1) can be used to determine the type of CH as 
well as its activity. Clinical diagnosis has been described 
as the diagnostic gold standard.13 
  Nuclear imaging is capable of providing physiological 
details of CH using radionuclide-labeled tracers.14 
Examples of different types of nuclear imaging include 
planar scintigraphy, single-photon emission computed 
tomography (SPECT) and PET. SPECT and planar scin-
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tigraphy utilize the radionucleotide technetium-99m-
labelled methylene diphosphonate (99mTc-MDP), while 
PET utilizes the radionucleotide [18F]-fluoride.15 Prior 
to the development of 99mTc-MDP, [18F]-fluoride was 
the standard radionucleotide tracer for SPECT.15 Planar 
scintigraphy produces a two-dimensional image, as 
opposed to SPECT and PET, which produce three-
dimensional images. Bone scintigraphy has high sen-
sitivity and low specificity for bone metabolism, meaning 
that it can identify when a change in bone metabolism 
is present but is limited in its ability to differentiate 
among various conditions (e.g., bone healing, growth, 
infection, arthritic changes, or tumors).14
  Generally when condyles are being evaluated with 
bone scintigraphy, a difference in uptake levels of less 
than 10% indicates either normal condyles or individuals 
without progressive asymmetry.13 A meta-analysis by 
Saridin et al.13 found that the SPECT technique of bone 
scintigraphy had a significantly higher sensitivity (0.90) 
in detecting unilateral CH than the planar technique 
(0.71) (p = 0.04). However, no difference in specificity 
was found between these two techniques. PET has 
been described as having better spatial resolution than 
SPECT.15 Further research is needed to establish a more 
formalized method for scintigraphy analysis. The current 
literature provides various methods such as comparing 
right and left condylar activity in the form of a per-
centage or ratio and comparing condylar activity to a 
different bony landmark such as the lumbar vertebrae.13 
An attempt was made to relate SPECT findings to histo-
pathological differences in CH, in which SPECT was 
found insufficiently sensitive to detect histopathological 
differences.16
Classification and clinical characteristics
  Temporomandibular joint CH has been described as a 
rare unilateral growth of the mandibular condyle. This 
growth causes both functional and esthetic problems, 
which often manifest as facial asymmetry, occlusal inter-
ferences (Figure 2), and joint dysfunction that can lead 
to pain.1 Excessive growth can occur in several different 
locations in the mandible. The growth can be the result 
of an enlarged condyle, an elongated condylar neck, or 
outward bowing or downward growth of the body and 
ramus.17 Due to the variations in locations of excessive 
growth, multiple classification systems have been de-
Figure 1. Scintigraphy show-
ing activity in the left con-
dyle.
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veloped to better characterize the pathology. 
  Obwegeser and Makek3 developed a classification 
system based on the asymmetry and predominant 
growth vector (Table 1). In their article, they classified 
CH into 3 different categories. They defined Type 1 as 
hemimandibular elongation, with excessive growth dis-
played in the horizontal vector. Type 1 CH is associated 
with chin deviation toward the unaffected side, with 
no corresponding vertical asymmetry. Due to the over-
growth, the mandibular midline is also shifted to the 
contralateral side. As a result, the contralateral man-
dibular molars often deviate lingually in order to remain 
in proper occlusion with the maxillary molars. If the 
contralateral molars are unable to adapt to the growth, 
a crossbite may develop. Normally, the condyle is un-
affected, but the neck is often misshapen and slender. 
The ramus is elongated, which is the basis for referring 
to Type 1 as hemimandibular elongation. Type 2 CH 
was defined as hemimandibular hyperplasia, which is 
associated with excessive growth in the vertical vector. It 
is often characterized by a sloping rima oris with mini-
mal chin deviation. Due to the excessive downward 
growth of the mandible, the maxillary molars on the 
affected side compensate by following the mandible’s 
downward growth. The maxillary alveolar bone on 
the ipsilateral side grows excessively to maintain 
occlusion. If the maxillary molars are not able to follow 
the excessive downward growth, an open bite on the 
affected side results. In Type 2 CH, the condyle often 
appears enlarged, and the head is usually irregular or 
deformed. The neck of the condyle has also been re-
ported as thickened and/or elongated.18 Type 3 CH is a 
combination of Types 1 and 2.
  Wolford et al.2 developed an updated classification 
system that they considered more inclusive of patho-
logies causing CH. Their report classifies CH into 
four different categories based on clinical, imaging, 
growth, and histological characteristics. This system 
was developed to classify CH into more specific types in 
order to provide optimal treatment to patients based on 
their specific disease characteristics (Table 2).
  In this system, Type 1 and 2 CH are similar to the cla-
ssification system developed by Obwegeser and Makek3 
with the following exceptions. Type 1 is characterized 
by an accelerated and prolonged growth that causes 
Table 1. Obwegeser and Makek classification3
Type Clinical findings Histological findings
Type 1 
   (Hemimandibular Elongation)
- Chin deviation towards contralateral side
- Midline shift to contralateral side
- Lingual deviation of contralateral  
      mandibular molars
- Possible posterior crossbite
- Excessive growth in the horizontal vector
- Condyle often unaffected
- Elongated mandibular ramus
- Misshapen and slender condylar neck
Type II 
   (Hemimandibular Hyperplasia)
- Sloping rima oris with minimal chin  
      deviation
- Supraeruption of maxillary molars on  
      affected side
- Possible open bite
- No midline shift
- Excessive growth in the vertical vector
- Enlarged and often irregularly shaped  
      condylar head
- Neck of condyle can be thickened  
      and/or elongated
Type III 
   (Combination of Type I and Type II)
- Chin deviation towards contralateral  
      side with a sloping rima oris
- Midline shift
- Possible open bite and/or cross bite
- Excessive growth in vertical and  
      horizontal vectors
- Enlarged condylar head, neck and ramus
- Irregularly shaped condylar head,  
      neck and/or ramus
Cited from the article of Obwegeser and Makek3 (J Maxillofac Surg 1986;14:183-208) with the original author’s permmission.
Figure 2. Clinical characteristics showing facial and 
occlusal deviation to the non-affected side.
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condylar and mandibular elongation and split into 1A 
and 1B. CH Type 1A is defined as mandibular elongation 
that occurs bilaterally, while CH Type 1B occurs unila-
terally. CH Type 2 consists of unilateral overgrowth of 
the condyle caused by an osteochondroma and results 
in vertical overgrowth of the mandible. Wolford et al.19 
further classified CH Type 2A and B. Type 2A results 
from vertical elongation of the condylar head and neck. 
Type 2B involves horizontal exophytic tumor growth 
of the condyle in addition to vertical elongation of the 
head and neck. CH Type 3 consists of other benign 
tumors that cause CH, including but not limited to 
osteomas, neurofibromas, and fibrous dysplasia, and 
results in unilateral facial enlargement. Type 4 CH 
is caused by malignant tumors that originate in the 
condyle and cause enlargement and facial asymmetry. 
Some malignant tumors attributed to Type 4 CH include 
chondrosarcoma, multiple myeloma, osteosarcoma, and 
Ewing sarcoma. 
  Classification systems have also been created based 
on histological findings in CH patients. Slootweg and 
Müller20 were among the first to create a histological 
classification system based on a study they conducted 
in 1986, in which they classified 22 patients into four 
categories based on histological findings in various 
layers of hyperplastic condyles. Specifically, they analy-
zed the fibrous articular layer, the undifferentiated 
mesenchymal layer, the transitional layer, and the hyper-
trophic cartilage layer and characterized each layer 
based on histological findings. CH Type 1 displayed a 
broad proliferation zone with an underlying thick layer 
of hyaline growth cartilage and bone that contained 
numerous cartilage islands. CH Type 2 demonstrated 
a patchier distribution of proliferation zones with a 
smaller number of cartilage islands. CH Type 3 was 
cha racterized by irregular-shaped masses of cartilage 
found in the bone of the condylar neck or encroaching 
onto the superficial articular layer. Type 3 displayed 
great distortion compared to the histological findings 
of normal condyles. Type 4 CH was commonly charac-
terized by a burned-out appearance of the condyle 
due to a very cell-poor fibrocartilaginous layer covering 
the subchondral bone plate. Slootweg and Müller20 
also noted that Type 4 CH did not demonstrate a 
proliferation layer of the hyaline growth cartilage like 
that seen in the other types. 
Table 2. Wolford, Movahed, and Perez classification2
Type Clinical finding Histological finding
Type IA - Bilateral mandibular elongation
- No midline deviation
- Prognathism and Class III occlusion
- Accelerated and prolonged growth
- Excessive growth in the horizontal vector
- Condyle often unaffected
- Bilateral elongated mandibular head, neck and ramus
- Misshapen and slender condylar neck
Type IB -Unilateral mandibular elongation
 Chin deviation towards contralateral side
- Midline shift to contralateral side
- Lingual deviation of contralateral mandibular molars
- Possible posterior crossbite
- Ipsilateral Class III occlusion
- Excessive growth in the horizontal vector
- Condyle often unaffected
- Elongated mandibular head, neck and ramus
- Misshapen and slender condylar neck
Type IIA - Unilateral vertical elongation of face
- Sloping rima oris with minimal chin deviation
- Supraeruption of maxillary molars on affected side
- Possible open bite
- No midline shift
- Excessive growth in the vertical vector
- Condylar enlargement without horizontal exophytic 
growth off condyle
- Enlarged and often irregularly shaped condylar head
- Neck of condyle can be thickened and/or elongated
Type IIB - Unilateral vertical elongation of face
- Sloping rima oris with minimal chin deviation
- Supraeruption of maxillary molars on affected side
- Possible open bite
- No midline shift
- Excessive growth in the vertical vector
- Condylar enlargement with horizontal exophytic  
      growth off condyle
- Enlarged and often irregularly shaped condylar head
- Neck of condyle can be thickened and/or elongated
Type III - Unilateral facial enlargement - Caused by benign tumor growth
- Osteomas, neurofibromas, fibrous dysplasia, giant cell  
      tumor, chondroma, chondroblastoma, etc. 
Type IV - Unilateral facial enlargement - Caused by malignant tumor growth
- Caused by chondrosarcoma, multiple myeloma,  
      osteosarcoma, Ewing sarcoma, and metastatic lesions
Cited from the article of Wolford et al.2 (J Oral Maxillofac Surg 2014;72:567-95) with the original author’s permmission.
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  One of the first steps in managing CH cases is to 
determine if the mandible is actively growing. This 
deter mination can be made with many methods, but 
bone SPECT is an essential diagnostic tool to assess 
active growth.21 In this quantitative method, 99mTc-MDP 
is injected and absorbed into hydroxyapatite crystals and 
calcium in the bone.22 The bone is then scanned using 
the SPECT technique, and the hyperplastic condyle is 
quantitatively compared to the contralateral side.23 Often 
only a 0−5% difference in positive area is observed 
between normal condyles. Differences greater than 10% 
between two condyles are considered to indicate active 
growth due to CH.12 Therefore, a relative 55% uptake 
in the affected hyperplastic condyle is considered to 
be abnormal. Various other diagnostic methods can be 
used in addition to clinical examinations. Some other 
tests used to diagnose CH include three-dimensional 
tomography, standard radiology and cephalometry, and 
PET scans.24 
Surgical treatment options
  Once a detailed diagnosis of CH has been obtained, 
a treatment plan must be established. Treatment is 
primarily surgical and often accompanied by ortho-
dontics to correct occlusion. There is some controversy 
as to the ideal treatment option and time to treat. 
Treatment plans must consider the degree of asymmetry, 
resulting malocclusion, and condylar growth activity. 
Treatments to correct these problems can be approached 
jointly or separately. Usually, the selected strategy is 
dependent on growth activity and the patient’s age. 
As always, the patient’s demands and expectations are 
other important considerations. A study by Naini et al.25 
found that the patient’s desire for surgical intervention 
increases as the degree of asymmetry increases. In-
terestingly, they also found that asymmetries as small as 
5 mm can be noticed by the laypersons.
  CH treatment options are detailed from the simplest, 
least invasive to most complex procedures. One of 
the simplest procedures that can be performed is a 
man dibular ramus osteotomy of affected condyles. 
Motamedi26 treated 13 CH patients over a 10-year period 
with ramus osteotomies. Seven of the patients were 
treated with bilateral osteotomies alone, six were treated 
with unilateral osteotomies, and two of those procedures 
were combined with Le Fort I procedures. The study 
concluded that patients with unilateral CH can effec-
tively be treated with unilateral ramus osteotomies on 
the affected side. Bilateral osteotomies did not show any 
advantages over unilateral procedures; however, they 
may be indicated for patients with severely prognathic 
profiles and patients in whom unilateral osteotomies 
could possibly lead to excessive rotation of the un-
affected condyle. Combining the osteotomies with Le 
Fort I is effective in restoring occlusal discrepancies. 
  Many studies and case reports advocate high con-
dylectomies to treat CH. An analysis of 22 patients 
treated with high condylectomies who completed a 
4-year follow-up concluded that this method is a viable 
treatment option for patients, which often has a good 
and predictable surgical outcome.20 Lippold et al.27 also 
found that high condylectomy was an appropriate treat-
ment for unilateral CH. In their study, 4−5 mm was 
removed from the upper pole of the affected condyle, 
which appeared to effectively limit growth in CH. 
  The most complex surgical treatment for CH involves 
both a condylectomy and orthognathic surgery. In a 
classic study conducted by Wolford et al.19 in 2002, a 
group of patients was treated with both a high condy-
lectomy and orthognathic surgery, and this treatment 
was found to be very effective for correcting both 
fun ctional and esthetic problems resulting from CH. 
Another study supporting this claim found that com-
bined condylectomy and orthognathic surgery was 
successful both functionally and esthetically in 30 of 36 
patients.28 However, it also indicated that orthognathic 
surgery without any condylar intervention could possibly 
lead to future issues, because condylar growth may 
not be complete at the time of surgery. Thus, without 
treating the hyperplastic condyle, growth could possibly 
continue following orthognathic surgery.
  By contrast, orthognathic surgery alone may be an 
acceptable treatment if the excessive condylar growth 
has halted. Two studies treated a combined 44 CH pa-
tients after the excessive condylar growth was deter-
mined to have ceased.29 The cessation of condylar 
growth was confirmed by taking multiple SPECT images 
over a determined time period to compare the amount 
of active growth in each condyle. For all surgical op-
tions, timing and the patient’s wishes are critical in 
determining the correct treatment plan for CH.
  The literature pertaining to orthodontic treatment in 
patients with CH is very limited and generally consists 
of case reports. In a report of five cases by Rajkumar 
et al.30, the authors’ final assessment was that mild to 
severe CH can be treated with surgery alone. Other case 
reports have described the use of orthodontic treatment 
after surgical treatment to finalize occlusion. In a case 
involving two-stage surgery, Xavier et al.31 described 
their procedure as consisting of condylectomy followed 
by orthodontic treatment and orthognathic surgery. 
Each of these reports only describes the treatment used 
and what worked in those particular circumstances. 
No com parative literature is available on which to base 
a reliable treatment recommendation. If orthodontic 
treatment is chosen, it is vital to confirm that growth 
has halted before the orthodontic treatment begins. 
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CONCLUSION
  CH requires a thorough examination and diagnostic 
tools to accurately diagnose and treat. Patients often 
seek treatment due to facial asymmetry and resulting 
esthetic problems. Additional research is needed to 
establish a more standardized approach for diagnosing 
the activity of CH. Clinical examination, radiography, 
planar scintigraphy, SPECT, and PET are all diagnostic 
methods that can be utilized by clinicians when plan-
ning surgery. Longer follow-up studies must be com-
pleted to determine which treatment options are the 
most successful. Additionally, more studies are needed 
to understand the underlying causes of CH for earlier 
diagnosis and better treatment options. 
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